Table 4.

ASCs or CM attenuates the expression of markers of tissue remodelling and inflammation in PF (Late phase)

	Con (n = 5)	B (n = 5)	B + M (n = 4)	BAD7 (n = 5)	BCM7 (n = 5)
CTGF	1.12 ± 0.24	7.10 ± 1.28a	8.83 ± 1.65a	2.25 ± 0.25b	2.1 ± 0.25b , c
IL13	0.81 ± 0.09	4.68 ± 0.67a	5.67 ± 1.42a	1.01 ± 0.47b	1.81 ± 0.37b , c
MMP12	1.18 ± 0.27	34.3 ± 6.58a	43.83 ± 9.89a	10.9 ± 3.21b	20.46 ± 3.22b , c
TIMP1	1.05 ± 0.13	4.12 ± 0.81a	3.63 ± 0.36a	1.78 ± 0.33b	1.28 ± 0.06b , c
CCL2	1.12 ± 0.19	15.93 ± 3.05a	23.17 ± 5.65a	6.07 ± 0.96b	5.41 ± 1.32b , c
IL‐6	0.99 ± 0.81	4.68 ± 0.50a	5.88 ± 0.94a	1.70 ± 0.19b	1.43 ± 0.27b , c
COL1	0.90 ± 0.09	5.14 ± 1.48a	5.95 ± 1.49a	4.17 ± 0.82	5.32 ± 0.91
COL3	1.13 ± 0.20	4.19 ± 1.91	2.25 ± 0.49	1.45 ± 0.21	2.30 ± 0.32

Lung tissue harvested at the termination of the study was utilized for RT‐PCR analysis. Data presented are mean ± SEM, Con (n = 5), B (n = 5), B + M (n = 4), BAD7 (n = 5) and BCM7 (n = 5).

^a P ≤ 0.05, comparing B and B + M animals against the controls.

^b P ≤ 0.05, comparing BAD7 and BCM7 versus B.

^c P ≤ 0.05, comparing BCM7 versus B + M.